Brief: US FDA Revoked Emergency Use Authorization For Certain COVID Drugs As Of Dec 13

Vir Biotechnology

23/12/2024 17:16

Dec 23 (Reuters) - US FDA:
    * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR LILLY'S
BEBTELOVIMAB AS OF DEC 13 - WEBSITE
    * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR
ASTRAZENECA'S
EVUSHELD AS OF DEC 13 - WEBSITE
    * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR
REGENERON'S
REGEN-COV AS OF DEC 13 - WEBSITE
    * US FDA: REVOKED EMERGENCY USE AUTHORIZATION FOR GSK AND
VIR
BIOTECHNOLOGY'S SOTROVIMAB AS OF DEC 13 - WEBSITE

Further company coverage:  LLY.N 

 ((Reuters.Briefs@thomsonreuters.com;))